Classified as formulary restricted, for use as approved under COVID-19 Drug Protocol for Adults, if tocilizumab and sarilumab cannot be used or are not available.
Restricted to ID physicians for the management of COVID-19.
Sylvant is non-formulary for other indications. It is an IV infusion for a rare disease.
Reviewed: 26 May 2015 (Sylvant), 28 April 2020 (COVID-19)
Classified as formulary restricted, for use as approved under COVID-19 Drug Protocol for Adults, if tocilizumab and sarilumab cannot be used or are not available.
Restricted to ID physicians for the management of COVID-19.
Sylvant is non-formulary for other indications. It is an IV infusion for a rare disease.
Reviewed: 26 May 2015 (Sylvant), 28 April 2020 (COVID-19)